HemaSphere

HS 2021 cover art V2 resized no crop2

The official open access journal of EHA

HemaSphere, the official open access journal of EHA, aims to support hematology researchers by offering a fast and constructive review process and low publication fees. The journal publishes basic, translational and clinical research of very high level as well as insightful review articles with recommendations for future research and clinical applications.

HemaSphere is fully indexed in PubMed Central (PMC), in Scopus, and in the following Clarivate Analytics products and categories:

  • SCIENCE CITATION INDEX EXPANDED (SCIE) - Hematology
  • CC/CLINICAL MEDICINE - Hematology
  • Essential Science Indicators - Clinical Medicine

As a newer journal, HemaSphere does not yet have an Impact Factor (Clarivate), but citations to individual articles can be followed in Web of Science. Clarivate recently completed an evaluation of HemaSphere using the Web of Science selection criteria, and their editors found HemaSphere continues to meet quality criteria and now also meets impact criteria. As such, HemaSphere is expecting its first Impact Factor in June 2022.

EHA members have the opportunity to publish for a discounted fee in HemaSphere.

HemaSphere is indexed in Scopus with a 2021 CiteScore of 5.1 (November 2021) - CiteScore is using a 4-year window to track citations and is updated monthly.

Read the latest articles

Discover our collection of open access articles published in HemaSphere.

Review articles

Explore our collection of Review articles published by HemaSphere.

Submit your paper

EHA members have the opportunity to publish for a discounted fee in HemaSphere.